Antidepressant drugs, convulsions and epilepsy

Area of Science:

• Pharmacology
• Clinical Neurology
• Drug Safety

Background:

• Non-monoamine oxidase inhibitor antidepressant drugs are associated with convulsant effects.
• Mianserin is a non-monoamine oxidase inhibitor antidepressant with known convulsant properties.

Purpose of the Study:

• To review evidence on the convulsant effects of non-monoamine oxidase inhibitor antidepressants.
• To compare the convulsant potential of mianserin with other drugs in its class.

Main Methods:

• Review of existing scientific literature and clinical evidence.
• Analysis of reported cases of seizures associated with mianserin and similar antidepressants.

Main Results:

• Mianserin demonstrates convulsant effects at therapeutic doses.
• Seizures have not been documented following mianserin overdose.
• The convulsant risk of mianserin appears comparable to other non-monoamine oxidase inhibitor antidepressants.
• Enzyme-inducing anti-epileptic drugs may reduce mianserin plasma concentrations and elimination half-life by inducing its metabolism.

Conclusions:

• Mianserin's convulsant effects are dose-dependent and comparable to other non-monoamine oxidase inhibitor antidepressants.
• Concurrent use of enzyme-inducing anti-epileptic drugs may alter mianserin pharmacokinetics.
• Further research into drug interactions and seizure risk with mianserin is warranted.